| Literature DB >> 24763140 |
Erich Loza Telleria1, Joshua B Benoit1, Xin Zhao1, Amy F Savage1, Sandesh Regmi1, Thiago Luiz Alves e Silva1, Michelle O'Neill1, Serap Aksoy1.
Abstract
The agents of sleeping sickness disease, Trypanosoma brucei complex parasites, are transmitted to mammalian hosts through the bite of an infected tsetse. Information on tsetse-trypanosome interactions in the salivary gland (SG) tissue, and on mammalian infective metacyclic (MC) parasites present in the SG, is sparse. We performed RNA-seq analyses from uninfected and T. b. brucei infected SGs of Glossina morsitans morsitans. Comparison of the SG transcriptomes to a whole body fly transcriptome revealed that only 2.7% of the contigs are differentially expressed during SG infection, and that only 263 contigs (0.6%) are preferentially expressed in the SGs (SG-enriched). The expression of only 37 contigs (0.08%) and 27 SG-enriched contigs (10%) were suppressed in infected SG. These suppressed contigs accounted for over 55% of the SG transcriptome, and included the most abundant putative secreted proteins with anti-hemostatic functions present in saliva. In contrast, expression of putative host proteins associated with immunity, stress, cell division and tissue remodeling were enriched in infected SG suggesting that parasite infections induce host immune and stress response(s) that likely results in tissue renewal. We also performed RNA-seq analysis from mouse blood infected with the same parasite strain, and compared the transcriptome of bloodstream form (BSF) cells with that of parasites obtained from the infected SG. Over 30% of parasite transcripts are differentially regulated between the two stages, and reflect parasite adaptations to varying host nutritional and immune ecology. These differences are associated with the switch from an amino acid based metabolism in the SG to one based on glucose utilization in the blood, and with surface coat modifications that enable parasite survival in the different hosts. This study provides a foundation on the molecular aspects of the trypanosome dialogue with its tsetse and mammalian hosts, necessary for future functional investigations.Entities:
Mesh:
Year: 2014 PMID: 24763140 PMCID: PMC3998935 DOI: 10.1371/journal.pntd.0002649
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Figure 1Overview of salivary gland transcriptome analysis.
A. Number of RNA-seq reads after quality control and removal of parasite reads. B. Reads per contigs for control salivary gland. C. Contigs enriched in salivary glands (SG-enriched data set) in relation to whole female fly transcriptome data. D. Contigs with higher or lower expression following parasite infection in the salivary glands. E. The abundance of reads and fold difference of expression per contig are shown from parasite infected (shown in red) and from normal (shown in white) salivary glands. Those denoted below the line indicate reduced expression while those above indicate increased expression. The red dots below the line indicate the 21 secreted peptide contigs that correspond to 56.8% of total contigs.
Figure 2Functional classification based on gene ontology (GO) analysis of differentially expressed contigs in uninfected and parasite infected flies.
A. Cell component. B. Molecular function. C. Biological Process.
Figure 3Gene ontology (GO) enrichment analysis of contigs increased during trypanosome infection in the salivary glands.
A. Pathways enriched determined through ProfCom [98], R-spider [46] and selected pathways (P<0.05). B. Enriched networks identified allowing for no missing genes based on Drosophila homologs determined through R-spider [46].
Figure 4Specific salivary gland contigs and proteins suppressed during trypanosome infection.
A. Fold change during salivary gland infection based on RNA-seq analysis from SG-enriched dataset that have a combined infected and control RPKM value of over 1000 from Table S1. The combined infected and control RPKM value is shown next to each bar. B. Percent of RNA-seq reads represented by the contigs with decreased expression during trypanosome infection. C. Total protein profile analyzed by SDS-PAGE analysis from one pair of infected and control salivary glands, one representative sample is shown. D. Western blot analysis of Tsal1, TSGF-1, TSGF-2 as well as Tubulin from control and infected SG.
Host immunity genes from tsetse differentially expressed in infected SG compared to uninfected SG.
| GTPases | Fold change | Bonferroni | Control RPKM | Infected RPKM | |
| ab-tri_asb-57940 | GTPase Rab1/YPT1 small G protein superfamily | 3.120301 | 9.8E-05 | 26.56479 | 83.19823 |
| ab-tri_asb-12950 | GTPase Rab2 small G protein superfamily | 4.617021 | 0.015397 | 9.364569 | 43.45896 |
| ab-tri_asb-7076 | GTPase Ran/TC4/GSP1 mall G protein superfamily | 4.05395 | 0 | 51.76676 | 210.8207 |
| ab-tri_asb-4403 | Rab30, isoform B | 5.007407 | 3.1E-06 | 13.45945 | 67.75173 |
| ab-tri_asb-14790 | Rab protein 1 | 4.185714 | 9.49E-11 | 48.94724 | 205.5537 |
|
| |||||
| ab-tri_asb-15967 | Ubiquinol-cytochrome C reductase complex 11 kDa protein | 2.594864 | 5.69E-11 | 69.95626 | 182.3178 |
| ab-tri_asb-5799 | ubiquitin activating enzyme 1 | 3.716578 | 0.000123 | 18.6399 | 69.63385 |
| ab-tri_asb-35890 | ubiquitin conjugating enzyme, isoform A | 4.410405 | 1.31E-06 | 17.22152 | 76.45615 |
| ab-tri_asb-55539 | ubiquitin protein ligase | 2.991597 | 0.002685 | 23.78252 | 71.3125 |
|
| |||||
| ab-tri_asb-23380 | TEP2 protein | 7.843434 | 1.14E-10 | 19.72284 | 155.5768 |
| ab-tri_asb-57751 | thiolester containing protein III | 62.875 | 9.74E-09 | 0.817314 | 50.37243 |
|
| |||||
| ab-tri_asb-55758 | serine protease inhibitor 6 | 24.55 | 0 | 7.951141 | 196.8012 |
| ab-tri_asb-16075 | serine protease inhibitor 4 | 18.68657 | 8.54E-11 | 6.66225 | 125.4431 |
|
| |||||
| ab-tri_asb-20511 | salivary C-type lectin | −2.82524 | 0.000129 | 145.1698 | 51.60276 |
| ab-tri_asb-55955 | lectin | −2.39423 | 0.000933 | 173.9139 | 73.00219 |
Figure 5Overview of trypanosome transcriptome analysis.
A. Number of reads mapping to the parasite protein coding genes from blood and parasite-infected salivary gland RNA-seq libraries. B. Reads per gene from parasite-infected blood RNA-seq library and parasite-infected salivary gland RNA-seq libraries. C. Genes expressed at significantly higher levels in parasite-infected blood and in salivary glands.
DAVID enrichment analysis for genes with BSF and SG-parasite expression profiles.
| Higher in the blood | GO Number | Number of genes | Fold enrichment | Benjamini test |
| Nucleic acid transmembrane transporter | GO:0015932 | 9 | 4.074680924 | 0.032309994 |
| Glycolysis | GO:0006096 | 8 | 5.768518519 | 0.03099419 |
| Phosphorus metabolic process | GO:0006793 | 71 | 1.518999264 | 0.023106735 |
| Cytoskeleton | GO:0005856 | 10 | 3.973333333 | 0.004969771 |
| Protein kinase activity | GO:0004672 | 54 | 1.736749246 | 0.002219985 |
Specific genes increased in SG-parasites from infected salivary glands.
| Putative Function | Gene ID | RPKM SG | RPKM Blood | Fold Change |
| MCF/BSF | ||||
| Hypothetical Secretory Protein Conserved∧ | Tb927.10.10770 | 1794 | 48 | 37 |
| BARB Family*∧ | Tb09.244.2400; Tb09.244.2410; Tb09.244.2420; Tb09.244.2430; Tb09.244.2440; Tb09.244.2450; Tb09.244.2460; Tb09.244.2470; Tb09.244.2480; Tb09.244.2490; Tb09.244.2500; Tb09.244.2510; Tb09.244.2520; Tb09.244.2530 | 7688 | 247 | 31 |
| Pteridine transporter, putative Family*∧ | Tb927.1.2820; Tb927.1.2880 | 2700 | 136 | 20 |
| Hypothetical Protein Conserved Family*∧ | Tb927.7.360; Tb927.7.380; Tb927.7.400; Tb927.7.420; Tb927.7.440 | 1031 | 93 | 14 |
| Adenosine transporter*∧ | Tb927.3.590 | 315 | 23 | 14 |
| Purine nucleoside transporter (TbNT9)*∧ | Tb927.6.220 | 316 | 24 | 13 |
| Amino acid transporter 1, putative (AAT4/8)*∧ | Tb927.8.7610 | 1663 | 166 | 10 |
| Amino acid transporter, putative (AAT3)*∧ | Tb927.4.7740 | 1173 | 70 | 17 |
| Cation transporter, putative family*∧ | Tb11.01.0725; Tb11.01.0730; Tb11.01.0760; Tb11.01.0770 | 1049 | 99 | 11 |
| Folate transporter putative, Expression site-associated gene 10 (ESAG10) protein*∧ | Tb927.8.3620 | 311 | 53 | 6 |
| Hypothetical protein Family∧@ | Tb927.2.4760; Tb927.2.4920; Tb927.2.5290; Tb927.2.5300; Tb927.2.5310; Tb927.2.5320; Tb927.2.5330; Tb927.2.5340; Tb927.2.5350; Tb927.2.5360 | 851 | 200 | 4 |
| Hypothetical protein, conserved Family∧ | Tb11.02.3760; Tb11.02.3770 | 4450 | 1286 | 4 |
Specific genes increased in BSF parasites from mouse blood.
| Putative Function | Gene ID | RPKM BSF | RPKM MCF | Fold Change |
| BSF/MCF | ||||
| Hypothetical Protein Conserved | Tb11.02.4450 | 428 | 0.5 | 856.0 |
| Hypothetical Protein, Conserved | Tb927.4.1910 | 1237 | 54 | 22.9 |
| Hypothetical Protein, Conserved | Tb11.47.0021 | 1132 | 12 | 94.3 |
| Transferrin (ESAG6/7)*∧ | Tb927.7.3250; Tb927.7.3260 | 2582 | 52 | 49.7 |
| Hypothetical Protein, Conserved Zinc finger protein family member Putative (ZC3H11) | Tb927.5.810 | 6168 | 220 | 28.0 |
| Hypothetical Protein, Conserved Zinc finger protein family member, putative (ZC3H20) | Tb927.7.2660 | 975 | 34 | 28.7 |
| MSP-A*∧ | Tb11.02.5610; Tb11.02.5630; Tb11.02.5640 | 528 | 16 | 33.0 |
| RNA-binding protein, putative (RBP3) | Tb11.03.0550 | 481 | 6 | 76.0 |
| RNA-binding protein, putative (DRBD12) | Tb927.8.6650 | 127 | 3 | 43.0 |
| RNA-binding protein, putative (RBP9) | Tb11.01.3940 | 333 | 9 | 37.0 |
| RNA-binding protein, putative (RBP26) | Tb927.7.3730 | 250 | 16 | 15.0 |
| RNA-binding protein, putative (DRBD11) | Tb927.3.3940 | 235 | 22 | 11.0 |
| cyclin-like F-box proteins | Tb927.1.4650; Tb927.1.4580 | 964 | 102 | 10.0 |
| RNA binding protein (DRBD3) | Tb09.211.0560 | 861 | 107 | 8.0 |
| RNA-binding protein UBP1 (UBP1) | Tb11.03.0620 | 814 | 146 | 6.0 |
| Putative protein associated with differentiation Family@ (PAD1,3) | Tb927.7.5930; Tb927.7.5950 | 537 | 89 | 6.0 |
| adenosine transporter 2, putative (TbNT3 and 4) | Tb927.2.6200; Tb927.2.6220 | 230 | 5 | 46.0 |
| adenosine transporter 2, putative (TbNT6) | Tb927.2.6320 | 252 | 2 | 126.0 |
| glucose transporter, putative | Tb927.10.8510; Tb927.10.8520; Tb927.10.8530 | 90 | 9 | 100.0 |
| glycerol kinase, glycosomal (glk1) | Tb09.211.3540; Tb09.211.3560; Tb09.211.3570 | 517 | 3 | 172.3 |